價(jià)格 | ¥1098 | ¥1880 | ¥2900 |
包裝 | 50ul | 100ul | 200ul |
最小起訂量 | 50ul |
發(fā)貨地 | 上海 |
更新日期 | 2025-02-28 |
中文名稱(chēng):VSIG4 T淋巴細(xì)胞負(fù)調(diào)節(jié)蛋白抗體 | 英文名稱(chēng):VSIG4 |
品牌: 滬震生物 | 產(chǎn)地: 中國(guó)/上海 |
保存條件: -20°C | 純度規(guī)格: > 99% |
產(chǎn)品類(lèi)別: 抗體 一抗 | |
抗體名: V-set and immunoglobulin domain-containing protein 4; CRIg; V set and immunoglobulin domain containing 4; Z39IG; VSIG4_HUMAN. | 靶點(diǎn): 詳見(jiàn)說(shuō)明書(shū) |
宿主: Rabbit | 適應(yīng)物種: 詳見(jiàn)說(shuō)明書(shū) |
克隆性: 詳見(jiàn)說(shuō)明書(shū) | 濃度: 1mg/ml |
應(yīng)用范圍: WB=1:500-2000 ELISA=1:5000-10000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 (石蠟切片需做抗原修復(fù)) not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. | 標(biāo)識(shí)物: 詳見(jiàn)說(shuō)明書(shū) |
形態(tài): 液體 | 亞型: IgG |
免疫原: 詳見(jiàn)說(shuō)明書(shū) | 貨號(hào): Hz-R0479 |
用途范圍: 科研使用 | 規(guī)格: 50ul/100ul/200ul |
是否進(jìn)口: 否 | 是否單克隆: 詳見(jiàn)說(shuō)明書(shū) |
保質(zhì)期: 12個(gè)月 | 抗原來(lái)源: 詳見(jiàn)說(shuō)明書(shū) |
標(biāo)記物: 詳見(jiàn)說(shuō)明書(shū) | 產(chǎn)品用途: WB=1:500-2000 ELISA=1:5000-10000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 (石蠟切片需做抗原修復(fù)) not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
Rabbit Anti-VSIG4 Polyclonal Antibody
DATASHEET
Host:Rabbit
Target Protein:VSIG4
IR:Immunogen Range:81-160/399
Clonality:Polyclonal
Isotype:IgG
Entrez Gene:11326
Swiss Prot:Q9Y279
Source:KLH conjugated synthetic peptide derived from human VSIG4:81-160/399
Purification:affinity purified by Protein A
Storage:0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
Background:T cell activation by APCs is positively and negatively regulated by members of the B7 family. We have identified a previously unknown function for B7 familyrelated protein V-set and Ig domaincontaining 4 (VSIG4). Administration to mice of soluble VSIG4-Ig fusion molecules reduced the induction of T cell responses in vivo and inhibited the production of Th celldependent IgG responses. Unlike that of B7 family members, surface expression of VSIG4 was restricted to resting tissue macrophages and absent upon activation by LPS or in autoimmune inflammatory foci. The specific expression of VSIG4 on resting macrophages in tissue suggests that this inhibitory ligand may be important for the maintenance of T cell unresponsiveness in healthy tissues.
Size:50ul
Concentration:1mg/ml
Applications:WB(1:500-2000)
ELISA(1:5000-10000)
IHC-P(1:100-500)
IHC-F(1:100-500)
IF(1:100-500)
Cross Reactive Species:Human
Mouse
Rat
Dog
Cow
本品僅供科研使用。不能用于人和動(dòng)物治療等其它臨床診斷用!
成立日期 | 2014-05-08 (11年) | 注冊(cè)資本 | 100萬(wàn)元整 |
員工人數(shù) | 10-50人 | 年?duì)I業(yè)額 | ¥ 100萬(wàn)以內(nèi) |
主營(yíng)行業(yè) | 生化試劑,細(xì)胞培養(yǎng),蛋白組學(xué),分子生物學(xué),細(xì)胞生物學(xué) | 經(jīng)營(yíng)模式 | 工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱(chēng) | 價(jià)格 | 公司名稱(chēng) | 報(bào)價(jià)日期 | |
---|---|---|---|---|
詢價(jià) |
上海研生實(shí)業(yè)有限公司
|
2025-02-21 | ||
詢價(jià) |
VIP3年
|
上海嘉定區(qū)澄瀏公路52號(hào)
|
2025-02-27 | |
詢價(jià) |
VIP4年
|
上海冠導(dǎo)生物工程有限公司
|
2025-03-01 |